(Total Views: 425)
Posted On: 02/09/2020 7:14:30 PM
Post# of 153905
Then I think.
Patient #1 injected was given 700mg, but they discontinued because no Ccr5. Then patient #2, who we now call patient #1, was imo given 350mg, being in the mtnbc trial. But man it gets confusing with patients under several inds with cancer. Somehow they were able to keep everything straight with two hiv trials, but the different cancer patients, confusing. Probably because they are using the same number system for both, i.e. patient #5 could be in either emergency mbc or mtnbc, but for hiv they have always been clear and separated the patient count with combo vs mono.
Patient #1 injected was given 700mg, but they discontinued because no Ccr5. Then patient #2, who we now call patient #1, was imo given 350mg, being in the mtnbc trial. But man it gets confusing with patients under several inds with cancer. Somehow they were able to keep everything straight with two hiv trials, but the different cancer patients, confusing. Probably because they are using the same number system for both, i.e. patient #5 could be in either emergency mbc or mtnbc, but for hiv they have always been clear and separated the patient count with combo vs mono.
(0)
(0)
